引用本文:罗小琼,韦凤莲,罗章伟.1502例孕中期孕妇产前三联筛查结果分析[J].中国临床新医学,2009,2(9):940-941.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1203次   下载 955 本文二维码信息
码上扫一扫!
分享到: 微信 更多
1502例孕中期孕妇产前三联筛查结果分析
罗小琼,韦凤莲,罗章伟
533000 广西,百色右江民族医学院附属医院妇产科、放免科
摘要:
[摘要] 目的 探讨应用母亲血清标志物检查筛查胎儿唐氏综合征的临床价值。方法 应用ACCESS全自动免疫化学发光仪及配套试剂对妊娠l5~22周的1 502例孕妇进行血清AFP、β-hCG、μE3的测定,风险率>1∶380定为筛查阳性,再作羊水检查进行产前诊断。结果 1 502例孕妇中筛查为阳性者47例(3.13%),接受产前诊断者45例, 有3例21-三体核型胎儿,2例神经管畸形胎儿,1例18-三体综合征胎儿。结论 孕中期应用母亲血清生化指标筛查唐氏综合征胎儿并结合产前诊断是减少唐氏综合征患儿出生的有效方法。
关键词:  唐氏综合征  产前筛查  母亲血清标志物
DOI:10.3969/j.issn.1674-3806.2009.09.19
分类号:R 715
基金项目:
Analysis of triple test in prenatal screen for 1502 second trimester pregnant women
LUO Xiao-qiong, WEI Feng-lian, LUO Zhang-wei
Department of Obstetrics and Gynecology, the Affiliated Hospital of Youjiang Medical College for Nationalities, Baise 533000, China
Abstract:
[Abstract] Objective To study the clinical value of maternal serum marker screening for fetal Down′s syndrome.Methods Serum AFP、β-hCG、μE3 in 1 502 pregnant women ranged from 15th to 22nd gestational week were detected by automatic immunochemiluminescence apparatus and its corollary reagent, and the test results were regarded as positive when risk probability was over 1∶380. The amniocentesis was done for prenatal diagnosis.Results Forty-seven of 1 502 pregnant women were positive (3.13%). The prenatal diagnosis was performed in 45 pregnant women, of whom three were 21-Trisomy syndrome, two were neural tube defects and one was 18-Trisomy Syndrome.Conclusion It is an effective method to reduce infants with Down′s syndrome by detecting second trimester maternal serum biochemical markers and combining prenatal diagnosis.
Key words:  Down′s syndrome  Prenatal screening  Maternal serum marker